课题基金 / 基金详情

Evaluating the efficacy of combination Direct Acting Antiviral Agents for HCV in the Real World: Mimicking Randomized Trials with a Bayesian Approach

Evaluating the efficacy of combination Direct Acting Antiviral Agents for HCV in the Real World: Mimicking Randomized Trials with a Bayesian Approach
评估现实世界中直接作用抗病毒药物组合对 HCV 的疗效：用贝叶斯方法模拟随机试验
批准号：
327716
负责人：
Klein Marina B
金额：
$7.27万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-01-01 至 2016-01-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=327716&lang=en
关键词：
Bayesian Methods Direct Acting Antivirals Efficacy Hepatitis C Virus Hiv Observational Study Post-Marketing Trials

项目摘要

项目成果

Klein Marina B的其他基金

相似基金

相关文献

中文摘要
翻译
艾滋病毒-丙型肝炎（HCV）合并感染是加拿大和全世界日益关注的问题。有证据表明，合并感染的人发展终末期肝病的速度更快。预防终末期肝病和相关死亡的唯一方法之一是治愈
英文摘要
HIV- Hepatitis C (HCV) co-infection is a growing concern across Canada and worldwide. Evidence suggests that co-infected people develop endstage liver disease faster. One of the only ways to prevent endstage liver disease and associated deaths is to cure
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
26th International Workshop on HIV and Hepatitis Observational Databases (IWHOD)
After the Cure: Measuring the full impacts of direct-acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada
After the Cure: Measuring the full impacts of direct acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada
5th International HIV/Viral Hepatitis Co-infection IAS Satellite Meeting
海外基金